Major study of injection will track 'changes in participants' employment status'
The British government believes weight-loss drugs could play a role in its push to reduce the number of long-term unemployed people. The government says a $365 million investment from Eli Lilly will include a "major real-world study" on the effectiveness of tirzepatide, also known as Mounjaro, reports Reuters. The five-year study will track "health-related quality of life and changes in participants' employment status and sick days from work," according to the National Health Service's Health Innovation Center. Thousands of people in the Manchester area will be given the diabetes drug, an Ozempic competitor that has been described as "like a medical gastric bypass."